Fluorine-containing tetradentate cyclometalated platinum (II) complex, electronic device and application thereof

Fluorine-containing tetradentate cyclometalated platinum(II) complexes address charge balance issues in OLEDs, improving efficiency and lifetime while reducing costs, by enhancing charge transfer and stability in light-emitting layers.

JP2024169315AActive Publication Date: 2024-12-05ZHEJIANG UNIV OF TECH +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2024065998
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-23
Filing Date
2024-04-16
Publication Date
2024-12-05
Estimated Expiration
2044-04-16

AI Technical Summary

Technical Problem

Current OLED devices face challenges with charge balance in light-emitting layers due to inefficient hole and electron transport in host-guest systems, leading to reduced current efficiency and limited lifetime, and the high cost and complexity of platinum(II) and iridium(III) complex phosphorescent materials.

Method used

Development of fluorine-containing tetradentate cyclometalated platinum(II) complexes as guest phosphorescent materials, which improve charge distribution and balance in light-emitting layers, enhancing efficiency and extending device lifetime while reducing costs.

Benefits of technology

The fluorine-containing tetradentate cyclometalated platinum(II) complexes enhance current efficiency, extend device lifetime, and lower operating voltage in OLEDs, offering improved charge transfer and stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024169315000001_ABST
    Figure 2024169315000001_ABST
Patent Text Reader

Abstract

To provide a fluorine-containing tetradentate cyclometalated platinum (II) complex, an electronic device and application thereof.SOLUTION: A fluorine-containing tetradentate cyclometalated platinum (II) complex has a structure shown in formula (I) or formula (II). [In the formula (I) or formula (II), Fn indicates that there are one or more F substitutions on a benzene ring where it is located, where n is a positive integer from 1 to 5].SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention belongs to the technical field of organic electroluminescence, and in particular relates to a fluorine-containing tetradentate cyclometallated platinum(II) complex, an electronic device, and applications thereof. [Background technology]

[0002] Organic light-emitting diode (OLED) is a new generation full-color display and lighting technology. Compared with liquid crystal displays, which have the disadvantages of slow response speed, narrow viewing angle, need for backlight, and high power consumption, OLED is a self-emitting device that does not require backlight and is energy-saving, has low driving voltage, fast response speed, high resolution and contrast, wide viewing angle, and excellent low temperature characteristics. OLED devices can be made thinner and more flexible. They also have the advantages of low manufacturing cost, simple manufacturing process, and large area production. Therefore, OLED has a wide and huge application potential in the high-end electronic products and aerospace fields. With the gradual increase in investment, deeper research and development, and upgrade and improvement of manufacturing equipment, OLEDs will have a very wide range of application scenarios and development prospects in the future.

[0003] The core of OLED development is the design and development of emitting materials. Most of the emitting layers in currently applied OLED devices use a host-guest emitting mechanism in which a guest emitting material is doped into a host material. The energy gap of the host material is generally larger than that of the guest emitting material, and energy is transferred from the host material to the guest material, which is excited and emits light. Commonly used organic phosphorescent guest materials are heavy metal atoms such as iridium (III), platinum (II), and Pd (II). The commonly used phosphorescent organic materials mCBP (3,3´-bIs(9-carbazolyl)-bIphenyl) and 2,6-mCPy (2,6-bIs(9-carbazolyl)-pyrIdIne) have high efficiency and high triplet energy level, and when used as an organic material, they can efficiently transfer triplet energy from the organic emitting material to the guest phosphorescent emitting material. However, mCBP has the property of easily transporting holes but not easily transporting electrons, and 2,6-mCPy has poor hole transport, which leads to an imbalance of the charge in the emissive layer and a decrease in the current efficiency of the emissive layer. In addition, the number of heavy metal phosphorescent organic complex molecules, cyclometalated iridium(III) complex molecules, currently in use is limited. The abundance of metallic platinum element in the earth's crust and the annual production in the world are about 10 times that of metallic iridium element, and the amount of IrCl3 used to prepare iridium(III) complex phosphorescent materials is about 10 times that of metallic iridium element. . The price of H2O is also much higher than that of PtCl2 used in the preparation of platinum(II) complex phosphorescent materials. In addition, the preparation of iridium(III) complex phosphorescent materials involves four steps of reactions: iridium(III)-containing dimer, ligand exchange of iridium(III) intermediate, synthesis of mer-iridium(III) complex, and conversion of mer- to fac-iridium(III) complex isomer, which greatly reduces the total yield and reduces the raw material IrCl3 .This significantly reduces the utilization rate of H2O and increases the preparation cost of iridium (III) complex phosphorescent materials. In contrast, the preparation of platinum (II) complex phosphorescent materials requires only the final stage of ligand metallization and platinum salt design reaction, which has a high utilization rate of platinum element and can further reduce the preparation cost of platinum (II) complex phosphorescent materials. In short, the preparation cost of platinum (II) complex phosphorescent materials is much lower than that of iridium (III) complex phosphorescent materials. However, there are still technical difficulties in the development of platinum complex materials and devices, and how to improve the efficiency and life of devices has become an important research topic. Therefore, the development of new phosphorescent metal platinum (II) complexes is urgently needed. Summary of the Invention [Problem to be solved by the invention]

[0004] The present invention has been made in view of the above circumstances, and aims to provide a fluorine-containing tetradentate cyclometalated platinum(II) complex, an electronic device, and applications thereof. The fluorine-containing tetradentate cyclometalated platinum(II) complex of the present invention can provide excellent performance to a device as a guest phosphorescent material in an emission layer. Furthermore, when the tetradentate cyclometalated platinum(II) complex is combined with a specific host material, it is possible to not only improve the current efficiency of an electronic device, particularly an organic electroluminescence device, and extend the device life, but also reduce the operating voltage of the component. [Means for solving the problem]

[0005] The present invention provides a fluorine-containing tetradentate cyclometallated platinum(II) complex having a structure represented by formula (I) or formula (II).

[0006] [ka] [In formula (I) or formula (II), F n represents one or more F substitutions on the benzene ring where n is a positive integer of 1 to 5; R arepresents mono-, di-, tri-, tetra- or no substitution, and R a is selected from H or C1-C30 alkyl; R1, R2, and R3 are each independently selected from the group consisting of hydrogen, F, N, O, S, CN, a C1-C30 alkyl group, a C1-C30 cycloalkyl group, a C1-C30 cycloheteroalkyl group, a C1-C30 haloalkyl group, a C6-C60 aryl group, and a C6-C60 heteroaryl group.

[0007] Preferably, at least one hydrogen atom of R1, R2, and R3 may be replaced with deuterium or F.

[0008] Preferably, R1 and R3 are each independently selected from hydrogen or a C1-C30 alkyl group.

[0009] More preferably, each R2 is independently selected from hydrogen, deuterium, CN, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C1-C30 heteroalkyl group, a substituted or unsubstituted C1-C30 cycloalkyl group, a substituted or unsubstituted C1-C30 cycloheteroalkyl group, a substituted or unsubstituted C1-C30 haloalkyl group, a substituted or unsubstituted C6-C60 aryl group, and a substituted or unsubstituted C6-C60 heteroaryl group, and the heteroatoms on the heteroalkyl group, cycloheteroalkyl group, or heteroaryl group are selected from one or more of O, S, and / or N.

[0010] More preferably, the fluorine-containing tetradentate cyclometallated platinum(II) complex is selected from any one of the chemical structures shown below, in which "D" represents deuterium.

[0011] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0012] The present invention also provides the application of the fluorine-containing tetradentate cyclometallated platinum(II) complex having the structure represented by the above formula (I) or formula (II) in electronic devices.

[0013] Examples of the electronic device include organic electroluminescent devices (OLEDs), organic integrated circuits (O-ICs), organic field effect transistors (O-FETs), organic thin film transistors (O-TFTs), organic light emitting transistors (O-LETs), organic solar cells (O-SCs), organic photodetectors, organic photoreceptors, organic field quenchers (O-FQDs), light emitting electrochemical cells (LECs), and organic laser diodes (O-lasers).

[0014] In another aspect, the present invention also provides an organic electroluminescent device comprising a fluorine-containing tetradentate cyclometallated platinum(II) complex having the structure represented by formula (I) or formula (II) above.

[0015] The organic electroluminescence device further comprises a cathode, an anode, and an organic functional layer interposed between the anode and the cathode, and the organic functional layer contains a fluorine-containing tetradentate cyclometallated platinum(II) complex having a structure represented by formula (I) or formula (II) as described above.

[0016] Preferably, the organic functional layer includes a light-emitting layer, and the light-emitting layer contains a tetradentate cyclometallated platinum(II) complex having the structure represented by formula (I) or formula (II) above.

[0017] The light-emitting layer also contains a fluorescent doping material selected from one or more of the compounds represented by formulae (BN1) to (BN5).

[0018] [ka] [In the formula, X is O, S, Se or NR 300 and X 1 , X 2 , X 3 , X 4 are each independently represented by O, S, Se or N, R b ~R e R each independently represents mono-, di-, tri-, tetra- or no substitution. b ~R e are each independently selected from the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group; R 11 each independently represents the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group.

[0019] Preferably, R4, R5, R6, and R9 are each independently selected from a substituted or unsubstituted diphenylamine, a substituted or unsubstituted carbazolyl group, and the substitution may be multiple times. When the substituent is present, the substituent is selected from a deuterium atom, a C1-C30 alkyl group, and a C6-C30 aryl group.

[0020] Preferably, R7 to R8 and R 10 ~R 11 are each independently selected from the group consisting of hydrogen, a C1-C30 alkyl group, and a C6-C60 aryl group.

[0021] More preferably, R4 to R 11 At least one hydrogen atom may be replaced with deuterium.

[0022] In addition, the fluorescent doping material is selected from any one of the chemical structural formulas shown below, in which Ph represents a phenyl group, and D4 and D5 represent substitutions with 4 and 5 deuterium atoms, respectively.

[0023] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0024] In another aspect, the present invention also provides an organic optoelectronic device comprising a substrate layer, a first electrode on the substrate, an organic light-emitting functional layer on the first electrode, and a second electrode on the organic light-emitting functional layer, the organic light-emitting functional layer containing a fluorine-containing tetradentate cyclometallated platinum(II) complex having the structure represented by formula (I) or formula (II) above. For example, the platinum(II) complex may be included in the organic light-emitting functional layer as a light-emitting material.

[0025] The organic light-emitting functional layer also contains a fluorescent doping material having at least one of the compounds represented by the above formulas (BN1) to (BN5).

[0026] The present invention also provides a composition containing a tetradentate cyclometallated platinum(II) complex having the structure represented by the above formula (I) or formula (II). Preferably, the composition also contains a fluorescent doping material having any one or more of the compounds represented by the above formulas (BN1) to (BN5).

[0027] The present invention also provides a formulation containing a fluorine-containing tetradentate cyclometallated platinum(II) complex having the structure represented by the above formula (I) or formula (II) or the above composition and at least one solvent. The solvent is not particularly limited, and those well known to those skilled in the art can be used, such as unsaturated hydrocarbon solvents such as toluene, xylene, mesitylene, tetralin, decalin, bicyclohexyl, n-butylbenzene, sec-butylbenzene, and tert-butylbenzene, halogenated saturated hydrocarbon solvents such as carbon tetrachloride, chloroform, dichloromethane, dichloroethane, chlorobutane, bromobutane, chloropentane, bromopentane, chlorohexane, bromohexane, chlorocyclohexane, and bromocyclohexane, halogenated unsaturated hydrocarbon solvents such as chlorobenzene, dichlorobenzene, and trichlorobenzene, ether solvents such as tetrahydrofuran and tetrahydropyran, and ester solvents such as alkyl benzoates.

[0028] Preferably, the composition also contains a fluorescent doping material selected from any one or more of the compounds represented by formulae (BN1) to (BN5).

[0029] The present invention also provides a display or lighting device comprising one or more of the above organic optoelectronic devices. Effect of the Invention

[0030] Compared with the prior art, the advantages of the present invention include: The present invention provides a phosphorescent material of a fluorine-containing tetradentate cyclometalated platinum(II) complex. By introducing fluorine atoms into the appropriate positions of the ligand, the charge distribution in the excited state is improved, and the excited state of the material is increased to include a charge transfer state ( 3 MLCT), which is beneficial for improving the emissivity and extending the device life. The material of the present invention has good chemical and thermal stability, and is easy to fabricate deposition-type OLED devices. After being combined with a fluorescent doping material, the transport of holes and electrons is balanced, and the energy transfer between the host and the guest is more efficient. The organic electroluminescent device fabricated using the compound of the present invention as the emitting layer has obvious improvements in current efficiency and life, and the lighting voltage is greatly reduced. Especially when combined with a phosphorescent-sensitized boron-containing compound, the color purity of the light of the device can be improved. [Brief description of the drawings]

[0031] [Figure 1] FIG. 1 shows room temperature emission spectra of the prepared platinum complexes Pt1 to Pt6 in dichloromethane solution. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0032] The present invention will be described in detail below. The following description of the components may be based on a representative embodiment or specific example of the present invention, but the present invention is not limited to such an embodiment or specific example.

[0033] As used herein, the term "substituted" includes all permissible substituents of organic compounds. In a broad aspect, the permissible substituents include cyclic and acyclic, branched and unbranched, carbocyclic and heterocyclic, aromatic and nonaromatic substituents of organic compounds. Illustrative substituents include, for example, those described below. The permissible substituents can be one or more and can be the same or different for appropriate organic compounds. For purposes of this invention, heteroatoms (e.g., nitrogen) can have hydrogen substituents and / or any permissible substituents of organic compounds described herein that satisfy the valences of the heteroatoms. This invention is not intended to be limited in any manner with respect to the permissible substituents of organic compounds. Similarly, the terms "substituted" or "substituted with" have the implication that such substitution is in accordance with the permissible valences of the atom and the substituent being substituted, and that the substitution results in a stable compound (e.g., a compound that does not spontaneously transform, e.g., rearrange, cyclize, or eliminate). Moreover, in certain embodiments, it is contemplated that individual substituents may be optionally further substituted (i.e., may or may not be further substituted), unless clearly indicated to the contrary.

[0034] In the definitions of various terms, "R1" to "R 11 " is used herein as a generic symbol to represent various specific substituents. These symbols may be any substituent and are not limited to the substituents disclosed herein, and when defined as a certain substituent in one instance, it may be defined as a different substituent in another instance.

[0035] As used herein, "R 1 ", "R 2 ", "R 3 " ... "R n " (where n is an integer) may independently contain one or more of the groups listed above. For example, R 1When is a straight chain alkyl group, one of the hydrogen atoms of the alkyl group may be optionally replaced by a hydroxyl group, an alkoxy group, an alkyl group, a halogen, etc. Depending on the group selected, the first group may be incorporated into the second group, or the first group may be pendant (i.e., attached) to the second group. For example, in the phrase "an alkyl group that includes an amino group," the amino group may be attached within the backbone of the alkyl group. Optionally, the amino group may be attached to the backbone of the alkyl group. The nature of the group selected will determine whether the first group is incorporated into or attached to the second group.

[0036] As used herein, the term "alkyl" refers to a branched or unbranched saturated hydrocarbon group having 1 to 60 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group may be cyclic or acyclic. The alkyl group may be branched or unbranched. The alkyl group may also be substituted or unsubstituted. For example, the alkyl group may be substituted with one or more groups, including, but not limited to, substituted alkyl, cycloalkyl, alkoxy, amino, halogen, hydroxy, nitro, silyl, sulfo-oxo, or mercapto, as described herein.

[0037] As used herein, the term "aryl" refers to a group of 5 to 60 carbon atoms containing any carbon-based aromatic group, including but not limited to benzene, naphthalene, phenyl, biphenyl, phenoxybenzene, anthryl, phenanthrenyl, and the like. The term "aryl" also includes "heteroaryl", which is defined as a group containing an aromatic group with one heteroatom incorporated within the ring of the aromatic group. Examples of heteroatoms include but are not limited to nitrogen, oxygen, sulfur, and phosphorus. Similarly, the term "non-heteroaryl" is also included in the term "aryl" and is defined as a group containing an aromatic group that does not contain a heteroatom. The aryl group may be substituted or unsubstituted. Aryl groups may be optionally substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, halogen, hydroxy, carbonyl, azido, nitro, silyl, sulfo-oxo, or mercapto, as described herein.

[0038] As used herein, the term "amine" or "amino" refers to a group of the formula -NR 1 R 2 wherein R 1 and R 2 may be independently selected from hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl groups.

[0039] The compounds of the present invention may contain "optionally substituted" moieties. In general, the term "substituted", whether preceded by the term "optionally" or not, means that one or more hydrogens of the specified moiety are replaced with a suitable substituent. Unless otherwise indicated, an "optionally substituted" group may have a suitable substituent at each substitutable position of the group, and when one or more positions of any given structure are substitutable with one or more substituents selected from a specified group, the substituents may be the same or different at all positions. Combinations of substituents envisioned by the present invention are preferably those combinations that result in the formation of stable or chemically feasible compounds. Furthermore, in certain embodiments, it is contemplated that individual substituents may be optionally further substituted (i.e., may be further substituted or unsubstituted), unless clearly indicated to the contrary.

[0040] The structure of the compound may be represented by the following formula:

[0041] [ka]

[0042] This formula is understood to be the same as the formula:

[0043] [ka] [wherein n is usually an integer. That is, R n is a group consisting of five independent substituents R a(1) , R a(2) , R a(3) , R a(4) , R a(5) By "independent substituents" it is meant that each R substituent may be defined independently. For example, in one example, R a(m) is a halogen, R a(n) does not necessarily have to be a halogen in the examples.

[0044] The compounds disclosed herein can exhibit desirable properties and can have emission and / or absorption spectra that can be tailored by the selection of appropriate ligands. Additionally, the present invention can exclude any one or more compounds, structures, or portions thereof specifically described herein.

[0045] The compounds of the present invention can be prepared in a variety of ways, including but not limited to, those methods described in the examples provided herein.

[0046] It should be noted that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention.

[0047] The present application may be understood more readily by reference to the following specific embodiments and examples included therein.

[0048] Before the present compounds, devices and / or methods are disclosed and described, it is to be understood that unless otherwise specified, the present invention is not limited to specific synthetic methods (shown separately) or specific reagents (shown separately), and as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, exemplary methods and materials are described herein. All raw materials and solvents in the synthetic examples were commercially available unless otherwise specified, and solvents were used as is without further treatment.

[0049] The substrate of the present invention can be any substrate used in typical organic optoelectronic devices, and can be a glass or transparent plastic substrate, a substrate made of opaque materials such as silicon or stainless steel, or a flexible PI film. Different substrates have different mechanical strength, thermal stability, transparency, surface smoothness, and waterproof properties, and the direction of use varies according to the nature of the substrate. As the materials for the hole injection layer, hole transport layer, and electron injection layer, any material can be selected from known materials used in OLED devices, and the present invention is not particularly limited thereto.

[0050] Synthesis Examples The following examples of compound synthesis, composition, device, or method are only intended to provide a general approach to the industry and are not intended to limit the scope of patent protection. Data (amounts, temperatures, etc.) given in the patents are as accurate as possible, but may have some errors. Unless otherwise indicated, measurements are taken separately, temperatures are in °C or at ambient temperature, and pressures are close to ambient pressure.

[0051] In the following examples, the preparation method of the novel compound is provided, but the preparation of such compound is not limited to this method. The compound sought to be protected in the present invention is easy to modify and prepare in this technical field, so it can be prepared by the methods listed below or other methods. The following examples are merely examples and are not intended to limit the scope of protection of this patent. The temperature, catalyst, concentration, reactants, and reaction process can be changed, and different conditions can be selected for different reactants to prepare the compound.

[0052] 1 H NMR (500 MHz), 1 H NMR (400 MHz), 13 C NMR (126 MHz) spectra were measured on an ANANCE III (500M) nuclear magnetic resonance spectrometer. Unless otherwise stated, the nuclear magnetic resonance spectra were uniformly measured using DMSO-d or CDCl containing 0.1% TMS as the solvent. 1For H NMR spectra, TMS (δ = 0.00 ppm) is used as the internal standard when CDCl3 is used as the solvent. When DMSO-d6 is used as the solvent, TMS (δ = 0.00 ppm) or the residual DMSO peak (δ = 2.50 ppm) or the residual water peak (δ = 3.33 ppm) is used as the internal standard. 13 In the C NMR spectra, CDCl3 (δ = 77.00 ppm) or DMSO-d6 (δ = 39.52 ppm) was used as an internal standard. HPLC-MS was measured on an AgIlent 6210 TOF LC / MS mass spectrometer, and HRMS spectra were measured on an AgIlent 6210 TOF LC / MS liquid chromatograph time-of-flight mass spectrometer. 1 H NMR spectral data: s = singlet, d = doublet, t = triplet, q = quartet, p = quIntet, m = multiplet, br = broad.

[0053] (Synthesis of intermediate 1) The synthetic route of intermediate 1 is as follows.

[0054] [ka]

[0055] (1) A (256 mg, 1.0 mmol, 1.0 eq), B (210 mg, 1.5 mmol, 1.5 eq), tetrakis(triphenylphosphine)palladium (29 mg, 0.025 mmol, 0.025 eq), and tripotassium phosphate (425 mg, 2.0 mmol, 2.0 eq) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and nitrogen replacement was performed three times. Dioxane (8 mL) and water (2 mL) were then added under nitrogen protection, and the mixture was stirred in a 60°C oil bath and reacted for 12 hours, after which it was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain product C as a red liquid (183 mg, 88% yield). It was used as is in the next step.

[0056] (2) Into a dried sealed tube equipped with a magnetic stir bar, C (180 mg, 0.71 mmol, 1.0 equivalent), D (130 mg, 0.65 mmol, 1.1 equivalent), tris(dibenzylideneacetone)dipalladium (6 mg, 0.065 mmol, 0.01 equivalent), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (16 mg, 0.026 mmol, 0.04 equivalent), and cesium carbonate (263 mg, 0.81 mmol, 1.25 equivalent) were added in that order, and the mixture was purged with nitrogen three times. Then, toluene (5 mL) was added under nitrogen protection, and the mixture was stirred in a 120°C oil bath and reacted for 12 hours. The mixture was then cooled to room temperature, and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=10:1) to obtain product E as a yellow solid (981 mg, 84% yield), which was used in the next step as it was.

[0057] (3) E (6.52 g, 17.4 mmol, 1.0 equiv.) and stannous chloride dihydrate (16 g, 69.6 mmol, 4.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and the atmosphere was replaced with nitrogen three times. Then, under nitrogen protection, ethanol (60 mL) and ethyl acetate (60 mL) were added, and the mixture was stirred in an oil bath at 78°C and reacted for 9 hours. After that, the mixture was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane = 5:1) to obtain intermediate 1 as a purple solid 5.7 g (yield 90%).

[0058] (Synthesis of intermediate 1-Cl) The synthetic route to intermediate 1-Cl is as follows.

[0059] [ka]

[0060] (1) In a dried sealed tube equipped with a magnetic stir bar, F (10 g, 50.7 mmol, 1.0 equivalent), G (13 g, 60.8 mmol, 1.2 equivalent), tris(dibenzylideneacetone)dipalladium (464 mg, 0.5 mmol, 0.01 equivalent), 2-(di-tert-butylphosphino)biphenyl (303 mg, 1.0 mmol, 0.02 equivalent), and sodium tert-butoxide (9.7 g, 101 mmol, 2.0 equivalent) were added in that order, and the mixture was purged with nitrogen three times. Then, toluene (80 mL) was added under nitrogen protection, and the mixture was stirred in a 110° C. oil bath and reacted for 12 hours. The mixture was then cooled to room temperature, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate=30:1) to obtain product H as a yellow oily liquid (15 g, yield 91%).

[0061] (2) To a dry sealed tube equipped with a magnetic stir bar, H (28 g, 84.7 mmol, 1.0 equiv.) and hydrobromic acid (69 g, 0.847 mmol, 10.0 equiv.) were added sequentially, and the mixture was stirred in an oil bath at 120° C. for 12 h, after which it was cooled to room temperature and the solvent was removed under reduced pressure. The resulting crude product was made into a paste and filtered to give Product I as a white solid, 26 g (97% yield).

[0062] (3) In a dried sealed tube equipped with a magnetic stir bar, I (5 g, 15.8 mmol, 1.0 equiv), J (3.3 g, 17.4 mmol, 1.1 equiv), cuprous iodide (300 mg, 1.58 mmol, 0.1 equiv), 2-picolinic acid (389 mg, 3.16 mmol, 0.2 equiv), and tripotassium phosphate (6.7 g, 31.6 mmol, 2.0 equiv) were added in sequence, and nitrogen was replaced three times. Dimethyl sulfoxide (50 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 100 °C and reacted for 12 hours, then cooled to room temperature, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate = 20:1) to obtain the product intermediate 1-Cl as a white solid 5.3 g (yield 79%).

[0063] It should be noted that the above only provides one possible preparation scheme for the intermediates of the present invention, and the intermediates required in each example can be prepared by referring to the synthesis process of intermediate 1 and intermediate 1-Cl. The preparation of these intermediate compounds is not limited to this method. The preparation can be carried out by the methods listed above or other methods commonly known in the art, and does not limit the protection scope of the present invention.

[0064] Example 1: Synthesis of Pt1 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent light-emitting material Pt1 is as follows.

[0065] [ka]

[0066] Synthesis of intermediate (1-NH): 1 (363 mg, 1.0 mmol, 1.0 equiv.), 1-Cl (470 mg, 1.1 mmol, 1.1 equiv.), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv.), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv.), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv.) were added in sequence to a dry sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Toluene (5 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 100° C. for 12 hours, after which it was cooled to room temperature and the solvent was removed under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate = 30:1) to obtain the product 1-NH as a pale green foamy solid (580 mg, 77% yield), which was used in the next step as it was.

[0067] Synthesis of ligand L1: 1-NH (580 mg, 0.77 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (251 mg, 1.54 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and nitrogen replacement was performed three times. Triethyl orthoformate (10 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours, after which it was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L1 as a pale green foamy solid 483 mg (yield 69%). 1 H NMR (500 MHz, DMSO-d6): δ 1.09 (d, J = 7.0 Hz, 6H), 1.19 (d, J = 7.0 Hz, 6H), 1.32 (s, 9H), 2.36-2.42 (m, 2H), 7.24 (dd, J = 8.5, 6.0 Hz, 1H), 7.33 - 7.40 (m, 3H), 7.45 - 7.51 (m, 3H), 7.55 (d, J = 2.5 Hz, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.69 - 7.76 (m, 5H), 7.79 (q, J = 3.0Hz, 4H), 7.88 - 7.93 (m, 2H), 8.01 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 8.0 Hz, 1H), 8.35 (d, J = 8.5 Hz, 1H), 8.60 (d, J = 5.5 Hz, 1H), 10.62 (s, 1H).

[0068] Synthesis of Pt1: In a dried sealed tube equipped with a magnetic stir bar, L1 (483 mg, 0.53 mmol, 1.0 equiv.), (1,5-cyclooctadiene) platinum dichloride (198 mg, 0.53 mmol, 1.0 equiv.) and sodium acetate (216 mg, 1.59 mmol, 3.0 equiv.) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was placed in an oil bath at 120 ° C and stirred, and reacted for 3 days, after which it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, dichloromethane was added to extract, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt1 as a yellow solid (162 mg, 32% yield). 1 H NMR (500 MHz, DMSO-d6): δ 0.97 (s, 9H), 1.14 (d, J = 6.5 Hz, 6H), 1.17 (d, J = 6.5 Hz, 6H), 2.84 - 2.92 (m, 2H), 6.36 (dd, J = 6.5, 4.5 Hz, 1H), 6.78 (d, J =1.0 Hz, 1H), 7.14 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.0 Hz, 1H),7.30 (d, J = 7.5 Hz, 2H), 7.37-7.41 (m, 5H), 7.46-7.52 (m, 2H), 7.54(s, 1H), 7.86 (d, J = 8.0 Hz, 2H), 7.89 (d, J = 8.5 Hz, 1H), 7.97 (dd, J = 9.0, 5.5 Hz, 2H), 8.14 (d, J = 7.0 Hz, 1H), 8.27 (d, J = 8.5 Hz, 1H), 8.65 (d, J = 6.0 Hz, 1H).

[0069] Example 2: Synthesis of Pt2 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt2 is as follows.

[0070] [ka]

[0071] Synthesis of intermediate (2-NH): 1 (363 mg, 1.0 mmol, 1.0 equiv), 2-Cl (531 mg, 1.1 mmol, 1.1 equiv), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv) were added in sequence to a dry sealed tube equipped with a magnetic stir bar. After nitrogen replacement was performed three times, toluene (5 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 100 °C and reacted for 12 h, then cooled to room temperature, and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate=30:1) to obtain the product 2-NH as a pale green foamy solid (530 mg, 87% yield), which was used in the next step as it was.

[0072] Synthesis of ligand L2: 2-NH (702 mg, 0.64 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (203 mg, 1.84 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and nitrogen replacement was performed three times. Triethyl orthoformate (10 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours, after which it was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L2 as a pale green foamy solid (600 mg, 72% yield). 1H NMR (500 MHz, DMSO): δ 1.15 (d, J = 5.0 Hz, 6H), 1.24 (d, J = 5.0 Hz, 6H), 1.37 (s, 9 H), 1.43 (s, 9 H), 2.39 - 2.48 (m, 2H), 7.29 (dd, J = 8.0, 6.0 Hz, 1H), 7.37 - 7.47 (m, 3H), 7.49 - 7.58 (m, 3H), 7.58 (t, J = 2.5 Hz, 1H), 7.59 (d, J = 2.5 Hz, 1H), 7.69 (d, J = 8.0 Hz, 1H), 7.74 (q, J = 2.0 Hz, 2H), 7.77-7.82 (m, 3H), 7.84 (s, 2H), 7.94-7.98 (m, 2H), 8.02 (d, J = 8.0 Hz, 1H), 8.30 (d, J = 8.0 Hz, 1H), 8.39 (d, J = 8.5 Hz, 1H), 8.64 (d, J = 5.0 Hz, 1H), 10.70 (s, 1H).

[0073] Synthesis of Pt2: In a dried sealed tube equipped with a magnetic stir bar, L2 (600 mg, 0.62 mmol, 1.0 equiv.), (1,5-cyclooctadiene) platinum dichloride (221 mg, 0.59 mmol, 1.0 equiv.) and sodium acetate (153 mg, 1.87 mmol, 3.0 equiv.) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was wrapped in tin foil to prevent light from entering, and the mixture was stirred in a 120 °C oil bath. After reacting for 3 days, it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, dichloromethane was added to extract, the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt2 as a yellow solid (100 mg, yield 84%). 1H NMR (500 MHz, DMSO-d6): δ 0.94 - 1.29 (m, 21H), 1.49 (s, 9H), 2.70-3.01 (m, 2H), 6.34 (dd, J = 6.0, 4.0 Hz, 1H), 7.06 (d, J = 1.5 Hz, 1H), 7.14 (d, J = 8.5 Hz, 1H), 7.26 (d, J = 8.5 Hz, 1H), 7.35-7.45 (m, 5H), 7.49 (t, J = 6.0 Hz, 1H), 7.59 (t, J = 8.5 Hz, 1H), 7.66 (s, 1H), 7.73 (d, J = 1.5 Hz, 1H), 7.84 (d, J = 8.5 Hz, 2H), 7.87 (d, J = 8.5 Hz, 1H), 7.93 - 8.01 (m, 2H), 8.13 (d, J = 8.0 Hz, 1H), 8.36 (d, J = 8.5 Hz, 1H), 8.59 (d, J = 6.5 Hz, 1H).

[0074] Example 3: Synthesis of Pt3 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt3 is as follows.

[0075] [ka]

[0076] Synthesis of intermediate (3-NH): 1 (363 mg, 1.0 mmol, 1.0 equiv.), 3-Cl (646 mg, 1.1 mmol, 1.1 equiv.), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv.), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv.), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv.) were added in sequence to a dry sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Toluene (5 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 100° C. for 12 hours, after which it was cooled to room temperature and the solvent was removed under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate = 30:1) to obtain the product 3-NH as a pale green foamy solid (730 mg, 80% yield), which was used in the next step as it was.

[0077] Synthesis of ligand L3: 3-NH (730 mg, 0.64 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (261 mg, 1.60 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Then, triethyl orthoformate (10 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours. After that, the mixture was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L3 as a pale green foamy solid (633 mg, 74% yield). 1H NMR (500 MHz, DMSO-d6): δ 0.93 (d, J = 4.5 Hz, 6H), 1.10 (t, J = 6.5 Hz, 12H), 1.20 (d, J = 6.5 Hz, 6H), 1.34 (s, 9H), 2.39-2.45 (m, 2H), 2.58-2.64 (m, 2H), 7.09 (dd, J = 2.0, 1.0 Hz, 1H), 7.22 (d, J =7.5 Hz, 2H), 7.28 (dd, J = 8.5, 6.0 Hz, 1H), 7.33-7.40 (m, 4H), 7.46-7.53 (m, 3H), 7.57 (d, J = 2.5 Hz, 1H), 7.66 (d, J = 8.5 Hz, 1H), 7.71-7.79 (m, 3H), 7.80 (s, 2H), 7.83 (t, J = 8.5 Hz, 1H), 7.87 (t, J = 2.5 Hz, 1H), 7.89-7.93 (m, 2H), 8.02 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 7.5 Hz, 1H), 8.36 (d, J = 8.5 Hz, 1H), 8.60 (d, J = 5.5 Hz, 1H), 10.65 (s, 1H)。

[0078] Synthesis of Pt3: In a dried sealed tube equipped with a magnetic stir bar, L3 (633 mg, 0.59 mmol, 1.0 equiv.), (1,5-cyclooctadiene) platinum dichloride (222 mg, 0.59 mmol, 1.0 equiv.) and sodium acetate (241 mg, 1.78 mmol, 3.0 equiv.) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was wrapped in tin foil to prevent light from entering, and the mixture was stirred in a 120 °C oil bath. After reacting for 3 days, it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, dichloromethane was added to extract, the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt3 as a yellow solid (476 mg, yield 72%). 1 H NMR (500 MHz, DMSO-d6): δ 0.70 - 1.64 (m, 33H), 2.77 - 3.21 (m, 4H), 6.34 (dd, J = 6.0, 4.0 Hz, 1H), 7.06 (d, J = 8.0 Hz, 1H), 7.13 (d, J = 8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H), 7.31-7.79 (m, 11H), 7.80-7.91 (m, 4H), 7.97 (dd, J = 5.5, 3.0 Hz, 2H), 8.13 (d, J = 6.5 Hz, 1H), 8.45 (d, J =8.0 Hz, 1H), 8.61 (d, J = 5.0 Hz, 1H).

[0079] Example 4: Synthesis of Pt4 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt4 is as follows.

[0080] [ka]

[0081] Synthesis of intermediate 4-NH: 2 (413 mg, 1.0 mmol, 1.0 equiv.), 2-Cl (531 mg, 1.1 mmol, 1.1 equiv.), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv.), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv.), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv.) were added in sequence to a dry sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Toluene (5 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 100° C. for 12 hours, after which it was cooled to room temperature and the solvent was removed under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate = 30:1) to obtain the product 4-NH as a pale green foamy solid 661 mg (yield 77%). Since it is easily oxidized and has low stability, it was used as it is in the next reaction.

[0082] Synthesis of ligand L4: 4-NH (661 mg, 0.77 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (251 mg, 1.54 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Then, triethyl orthoformate (10 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours. After that, the mixture was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L4 as a pale green foamy solid (500 mg, 64% yield). 1H NMR (500 MHz, DMSO-d6): δ 1.10 (d, J = 7.0 Hz, 6H), 1.19 (d, J = 6.5 Hz, 6H), 1.30 (s, 9H), 1.36 (s, 9H), 2.36-2.43 (m, 2H), 7.24 (dd, J = 8.5, 6.5 Hz,1H), 7.34 (t, J = 8.0 Hz, 1H), 7.45 - 7.54 (m, 5H), 7.65 (d, J =7.5 Hz, 1H),7.66 - 7.69 (m, 2H), 7.72 - 7.78 (m, 3H), 7.87 (s, 2H), 7.89 (d, J = 8.5 Hz, 2H), 7.96 (dd, J =8.0, 6.5 Hz,1H), 8.07 (d, J = 8.0 Hz, 2H), 8.24 (d, J = 7.5 Hz, 1H), 8.33 (d, J = 8.5 Hz, 1H), 8.58 (d, J = 5.5 Hz, 1H), 10.65 (s, 1H).

[0083] Synthesis of Pt4: In a dried sealed tube equipped with a magnetic stir bar, L4 (500 mg, 0.49 mmol, 1.0 equiv.), (1,5-cyclooctadiene) platinum dichloride (184 mg, 0.49 mmol, 1.0 equiv.) and sodium acetate (201 mg, 1.48 mmol, 3.0 equiv.) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was wrapped in tin foil to prevent light from entering, and the mixture was stirred in a 120 ° C oil bath. After reacting for 3 days, it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, and dichloromethane was added to extract, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt4 as a yellow solid (466 mg, yield 89%). 1H NMR (500 MHz, DMSO-d6): δ 0.92-1.25 (m, 21H), 1.48 (s, 9H), 2.9-3.15 (m, 2H), 6.34 (dd, J = 4.0, 2.0 Hz, 1H), 7.06 (d, J = 1.5 Hz, 1H), 7.15 (d, J = 8.5 Hz, 1H), 7.25 (d, J = 8.5 Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.44-7.51 (m, 1H), 7.59 (t, J = 7.5 Hz, 1H), 7.67-7.84 (m, 5H), 7.87 (d, J = 8.5 Hz, 1H), 7.90 (d, J = 8.0 Hz, 2H), 8.11 (d, J = 7.5 Hz, 1H), 8.15 (d, J = 8.5 Hz, 2H), 8.36 (d, J = 8.0 Hz, 1H), 8.57 (d, J = 6.5 Hz, 1H).

[0084] Example 5: Synthesis of Pt5 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt5 is as follows.

[0085] [ka]

[0086] Synthesis of intermediate 5-NH: 1 (363 mg, 1.0 mmol, 1.0 equiv.), 4-Cl (545 mg, 1.1 mmol, 1.1 equiv.), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv.), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv.), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv.) were added in sequence to a dry sealed tube equipped with a magnetic stir bar. After nitrogen replacement was performed three times, toluene (5 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 100° C. and reacted for 12 hours, then cooled to room temperature, and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate=30:1) to obtain the product 5-NH as a pale green foamy solid (525 mg, 64% yield), which was used directly in the next reaction.

[0087] Synthesis of ligand L5: 5-NH (525 mg, 0.64 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (208 mg, 1.28 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and nitrogen replacement was performed three times. Triethyl orthoformate (10 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours, after which it was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L5 as a pale green foamy solid 325 mg (yield 52%). 1H NMR (500 MHz, DMSO-d6): δ 1.08 (d, J = 6.5 Hz, 6H), 1.18 (d, J = 7.0 Hz, 6H), 1.33 (s, 9H), 2.40-2.46 (m, 2H), 7.31 (dd, J = 8.0, 6.0 Hz, 1H), 7.36 (dd, J =5.0, 3.0 Hz, 1H), 7.39 (d, J = 2.0 Hz, 2H), 7.47-7.50 (m, 1H), 7.52 (dd, J =5.5, 4.0 Hz, 1H), 7.64 (t, J =3.5 Hz, 2H), 7.72 (d, J = 8.5 Hz, 2H), 7.74 - 7.79 (m, 2H), 7.80 (s, 2H), 7.83 (s, 1H), 7.88-7.95 (m, 2H), 8.03 (d, J = 8.5 Hz, 1H), 8.07 (t, J = 2.0 Hz, 1H), 8.19 (s, 1H), 8.28 (d, J = 8.0 Hz, 1H), 8.39 (d, J = 8.5 Hz, 1H), 8.61 (d, J =5.0 Hz, 1H), 10.64 (s, 1H).

[0088] Synthesis of Pt5: In a dried sealed tube equipped with a magnetic stir bar, L5 (325 mg, 0.33 mmol, 1.0 eq), (1,5-cyclooctadiene) platinum dichloride (124 mg, 0.33 mmol, 1.0 eq) and sodium acetate (136 mg, 1.0 mmol, 3.0 eq) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was wrapped in tin foil to prevent light from entering, and the mixture was stirred in a 120 ° C oil bath. After reacting for 3 days, it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, dichloromethane was added to extract, the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt5 as a yellow solid (205 mg, yield 60%). 1H NMR (500 MHz, DMSO-d6): δ 0.96-1.27 (m, 21H), 2.81-3.01 (m, 2H), 6.37 (dd, J = 6.0, 2.0 Hz, 1H), 7.17 (d, J = 8.5 Hz, 1H), 7.29 (d, J =8.5 Hz, 1H), 7.33 - 7.41 (m, 6H), 7.46 (t, J = 7.5 Hz, 1H), 7.51 (td, J = 8.5, 7.0 Hz, 1H), 7.59 (td, J =7.0, 6.0 Hz, 1H), 7.86 (d, J = 2.0 Hz, 1H), 7.88 (d, J =8.0 Hz, 2H), 7.95 - 7.99 (m, 3H), 8.15 (d, J = 6.5 Hz, 1H), 8.42 (d, J = 8.5 Hz, 1H), 8.59 (d, J = 6.0 Hz, 1H).

[0089] (Example 6: Synthesis of Pt6) The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt6 is as follows.

[0090] [ka]

[0091] Synthesis of intermediate 6-NH: 3 (380 mg, 1.0 mmol, 1.0 equiv), 2-Cl (531 mg, 1.1 mmol, 1.1 equiv), tris(dibenzylideneacetone)dipalladium (27 mg, 0.03 mmol, 0.03 equiv), 2-(di-tert-butylphosphino)biphenyl (18 mg, 0.06 mmol, 0.06 equiv), and sodium tert-butoxide (192 mg, 2.0 mmol, 2.0 equiv) were added in sequence to a dry sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Toluene (5 mL) was then added under nitrogen protection, and the mixture was stirred in an oil bath at 100° C. for 12 hours, after which it was cooled to room temperature and the solvent was removed under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / ethyl acetate=30:1) to obtain the product 6-NH as a pale green foamy solid (604 mg, 73% yield), which was used directly in the next reaction.

[0092] Synthesis of ligand L6: 6-NH (604 mg, 0.73 mmol, 1.0 equiv.) and ammonium hexafluorophosphate (238 mg, 1.46 mmol, 2.0 equiv.) were added in sequence to a dried sealed tube equipped with a magnetic stir bar, and the mixture was purged with nitrogen three times. Then, triethyl orthoformate (10 mL) was added under nitrogen protection, and the mixture was stirred in an oil bath at 80°C and reacted for 10 hours. After that, the mixture was cooled to room temperature and the solvent was distilled off under reduced pressure. The resulting crude product was separated and purified by silica gel chromatography (eluent: dichloromethane) to obtain product L6 as a pale green foamy solid (538 mg, 75% yield). 1H NMR (500 MHz, DMSO-d6): δ 1.09 (d, J = 6.5 Hz, 6H), 1.18 (d, J = 7.0 Hz, 6H), 1.30 (s, 9H), 1.36 (s, 9H), 2.35-2.40 (m, 2H), 7.23 (dd, J = 8.5, 6.0 Hz, 1H), 7.31- 7.37 (m, 2H), 7.44-7.49 (m, 3H), 7.52 (t, J = 2.0 Hz, 1H), 7.53 (d, J = 2.5 Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.66 - 7.79 (m, 7H), 7.89 (s, 2H), 7.96 (dd, J = 8.0, 6.5 Hz, 1H), 8.24 (dd, J = 7.5, 7.0 Hz, 1H), 8.33 (d, J = 8.5 Hz, 1H), 8.58 (d, J = 5.5 Hz, 1H), 10.64 (s, 1H).

[0093] Synthesis of Pt6: In a dried sealed tube equipped with a magnetic stir bar, L6 (538 mg, 0.55 mmol, 1.0 equiv.), (1,5-cyclooctadiene) platinum dichloride (206 mg, 0.55 mmol, 1.0 equiv.) and sodium acetate (223 mg, 1.64 mmol, 3.0 equiv.) were added in sequence, and nitrogen replacement was performed three times. After that, diethylene glycol dimethyl ether (30 mL) was added under nitrogen protection, and nitrogen gas was bubbled for 30 minutes. After that, the mixture was wrapped in tin foil to prevent light from entering, and the mixture was stirred in a 120 ° C oil bath. After reacting for 3 days, it was cooled to room temperature, deionized water was added and stirred for 5 to 10 minutes to quench, dichloromethane was added to extract, the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was separated and purified by silica gel chromatography (eluent: petroleum ether / dichloromethane=2:1) ​​to obtain the product Pt6 as a yellow solid (463 mg, yield 82%). 1H NMR (500 MHz, DMSO-d6): δ 0.96-1.3 (m, 21H), 1.47 (s, 9H), 3.9-4.20 (m, 2H), 6.34 (dd, J =6.5, 6.0 Hz, 1H), 7.04 (d, J = 2.0 Hz, 1H), 7.11 (d, J = 8.5 Hz, 1H), 7.24 (d, J = 8.5 Hz, 1H), 7.28 - 7.33 (m, 1H), 7.36 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.47 (t, J =7.5 Hz, 1H), 7.58 (t, J =8.0 Hz, 1H), 7.68 - 7.88 (m, 8H), 8.10 (d, J = 8.0 Hz, 1H), 8.34 (d, J = 8.5 Hz, 1H), 8.53 (d, J = 6.5 Hz, 1H).

[0094] Spectral test experiments were carried out for the prepared platinum complexes Pt1, Pt4 to Pt6. Figure 1 shows the room temperature emission spectra of the prepared platinum complexes Pt1, Pt4 to Pt6 in dichloromethane solution. As can be seen from Figure 1, Pt1, Pt4 to Pt6 all emit deep blue light with high color purity. The maximum emission peak of Pt1 is 454 nm, which is a deep blue light, and its half-width is 19 nm. The present invention improves the charge distribution in the excited state by introducing fluorine atoms at appropriate positions of the ligand, and allows the excited state of the material to have more metal-to-pyridocarbene charge transfer states ( 3 This results in a blue phosphorescent material with a high-quality blue phosphorescent material, which is beneficial for improving the emissivity and extending the device lifetime.

[0095] (Example 7: Synthesis of Pt225) The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt225 is as follows.

[0096] [ka]

[0097] Pt225 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1. The synthesis yielded the target product 225-NH as a pale green foamy solid (804 mg) in a yield of 77%. The target product L225 was obtained as a pale green foamy solid (705 mg) in a yield of 63%. Molecular weight [M] + : 721.6. The desired product Pt225 was obtained as a yellow solid (606 mg) in 82% yield. Molecular weight [M+H] + :767.7.

[0098] (Example 8: Synthesis of Pt16) The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt16 is as follows.

[0099] [ka]

[0100] Pt16 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1. The synthesis yielded the target product 16-NH as a pale green foamy solid (804 mg) in a yield of 77%. The target product L16 was obtained as a pale green foamy solid (705 mg) in a yield of 63%. Molecular weight [M] + : 876.4. The desired product Pt16 was obtained as a yellow solid (606 mg) in 82% yield. Molecular weight [M+H] + :1068.4.

[0101] Example 9: Synthesis of Pt19 The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt19 is as follows.

[0102] [ka]

[0103] Pt19 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1. The synthesis yielded the target product 19-NH as a pale green foamy solid (906 mg) in a yield of 79%. The target product L19 was obtained as a pale green foamy solid (509 mg) in a yield of 59%. Molecular weight [M] + : 888.5. The desired product Pt19 was obtained as a yellow solid (203 mg) in 48% yield. Molecular weight [M+H] + :1080.2.

[0104] (Example 10: Synthesis of Pt21) The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt21 is as follows.

[0105] [ka]

[0106] Pt21 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1. The synthesis yielded the target product 21-NH as a pale green foamy solid (1.56 g) in a yield of 61%. The target product L21 was obtained as a pale green foamy solid (705 mg) in a yield of 70%. Molecular weight [M] + : 942.4. The desired product Pt21 was obtained as a yellow solid (432 mg) in 55% yield. Molecular weight [M+H] + :1134.5.

[0107] (Example 11: Synthesis of Pt24) The synthesis route of the tetradentate cyclometallated platinum(II) complex phosphorescent material Pt24 is as follows.

[0108] [ka]

[0109] Pt24 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1. The synthesis yielded the target product 24-NH as a pale green foamy solid (1.02 g) in a yield of 75%. The target product L24 was obtained as a pale green foamy solid (708 mg) in a yield of 63%. Molecular weight [M]+ : 756.4. The desired product Pt24 was obtained as a yellow solid (201 mg) in 50% yield. Molecular weight [M+H] + :948.3.

[0110] Example 12: Synthesis of Pt37 Pt37 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (562 mg) in a yield of 70%. Molecular weight [M+H] + :1065.1.

[0111] Example 13: Synthesis of Pt39 Pt39 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (624 mg) in a yield of 56%. Molecular weight [M+H] + :1067.1.

[0112] Example 14: Synthesis of Pt65 Pt65 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (661 mg) in a yield of 82%. Molecular weight [M+H] + :996.1.

[0113] (Example 15: Synthesis of Pt81) Pt81 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (484 mg) in a yield of 67%. Molecular weight [M+H] + :939.0.

[0114] (Example 16: Synthesis of Pt82) Pt82 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (455 mg) in a yield of 60%. Molecular weight [M+H] + :981.0.

[0115] Example 17: Synthesis of Pt86 Pt86 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (410 mg) in a yield of 66%. Molecular weight [M+H]+ :1019.1.

[0116] (Example 18: Synthesis of Pt111) Pt111 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (369 mg) in a yield of 58%. Molecular weight [M+H] + :1080.2.

[0117] Example 19: Synthesis of Pt112 Pt112 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (492 mg) in a yield of 82%. Molecular weight [M+H] + :1096.2.

[0118] (Example 20: Synthesis of Pt210) Pt210 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (471 mg) in a yield of 80%. Molecular weight [M+H] + :1089.2.

[0119] (Example 21: Synthesis of Pt233) Pt233 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (596 mg) in a yield of 74%. Molecular weight [M+H] + :835.9.

[0120] (Example 22: Synthesis of Pt311) Pt311 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (615 mg) in a yield of 68%. Molecular weight [M+H] + :931.9.

[0121] (Example 23: Synthesis of Pt318) Pt318 was synthesized by referring to the synthesis process and reaction conditions of compound Pt1, and the target product was obtained as a yellow solid (582 mg) in a yield of 66%. Molecular weight [M+H] + :881.8.

[0122] (Explanation of theoretical calculations) Density functional theory (DFT) was used to optimize the molecular geometries in the ground state (S0). The B3LYP functional was used for DFT calculations, with the 6-31G(d) basis set for C, H, O, and N atoms and the LANL2DZ basis set for Pt atoms.

[0123] [Table 1-1] [Table 1-2]

[0124] From the calculation data shown in Table 1, it can be seen that all of the compound materials provided by the present invention have a large energy gap (>3.20 eV) and can meet the needs of blue light materials. It can also be seen that the energy levels (HOMO and LUMO) of the frontier orbitals of the platinum (II) complex can be adjusted by controlling the structure of the ligand. Most of the LUMO of the pyridocarbene platinum (II) complex is in the pyridocarbene moiety, and the present invention improves the charge distribution in the excited state by introducing fluorine atoms at appropriate positions of the ligand, so that the excited state of the material is more of a charge transfer state from the metal to the pyridocarbene ( 3 The carbene can be made to have a MLCT (coordination bond) moiety, and since there exists both a coordinate bond and a feedback pi bond between the carbene and platinum(II), its stability is higher than that of the coordinate bond between pyridine and platinum(II). The above results help to increase the emissivity, thereby prolonging the lifetime of the device.

[0125] OLED device manufacturing As a reference method for the device embodiment, the present invention involves evaporating a p-type doping material or co-evaporating a p-type doping material with a hole injection material at a concentration of 1% to 50% on the surface or anode of an ITO glass having a light-emitting area of ​​2 mm x 2 mm to form a hole injection layer (HIL) of 5 to 100 nm and a hole transport layer (HTL) of 5 to 200 nm, and then forming an emissive layer (EML) of 10 to 100 nm (which may contain a compound of the present invention) on the hole transport layer, and forming an electron transport layer (ETL) of 20 to 200 nm and a cathode of 50 to 200 nm. If necessary, an electron blocking layer (EBL) is added between the HTL and EML layers, and an electron injection layer (EIL) is added between the ETL and the cathode to produce an OLED device. The OLED is tested by standard methods. The device materials according to the present invention can be obtained by known synthesis methods unless otherwise specified.

[0126] In a preferred embodiment, the structure of the device example 1 provided by the present invention is: ITO / P-4 (10 nm) / NPD (60 nm) / HTH-85 (5 nm) / Platinum(II) complex: HTH-85:ETH-45 (25 nm) (mass ratio of Pt-1:HTH-85:ETH-45 is 10:60:30) / ETH-5 (5 nm) / ET-14 (40 nm) / LiQ (1 nm) / Al (100 nm).

[0127] Device examples 2 to 22 and comparative example 1 were prepared using structures similar to device example 1, with the only difference being that Pt-2, Pt-3, Pt-4, Pt-5, Pt-225, Pt-16, Pt-19, Pt-21, Pt-24, Pt-37, Pt-39, Pt-65, Pt-81, Pt-82, Pt-86, Pt-111, Pt-112, Pt-210, Pt-233, Pt-311, Pt-318, and R1 were substituted for Pt-1 in device example 1. The luminescence properties of the comparative example and each device example prepared above by standard methods were tested and the data are shown in Table 2. The structural formulas of the devices involved are as follows, where P-4 is HATCN and ET-14 is BPyTP.

[0128] [ka]

[0129] [Table 2]

[0130] As can be seen from Table 2, compared with Comparative Example 1, Device Example 1 to Device Example 22 prepared in the present application show good device performance in terms of driving voltage, current efficiency and device life. The improvement in performance of each device example is based on the better electron transport ability of the specific compound material of the present invention. It can be seen that when this is used as a light-emitting layer material to manufacture an electronic device, it is possible to reduce the driving voltage while improving the current efficiency and device life. It shows that the compound provided by the present invention has a certain commercial application value.

[0131] In a preferred embodiment, the structure of device example 23 provided by the present invention is: ITO / P-4 (10 nm) / NPD (60 nm) / HTH-85 (5 nm) / platinum(II) complex: boron-containing compound: HTH-85:ETH-45 (25 nm) (mass ratio of Pt1:BN1-8:HTH-85:ETH-45 is 10:1:59:30) / ETH-5 (5 nm) / ET-14 (40 nm) / LiQ (1 nm) / Al (100 nm).

[0132] Device Examples 24 to 30 were each fabricated with a structure similar to Device Example 23, with the only difference being that the platinum(II) complex and boron-containing compound in Device Example 23 were replaced with the compounds listed in Table 3. The device structures and luminescence property data are shown in Table 3.

[0133] [Table 3]

[0134] As can be seen from Table 3, when the compound of the present invention is used as a sensitizing material and the boron-containing compound is used as an emitting material in a device, the performance of each device is greatly improved, indicating that the compound provided by the present invention has a certain commercial application value.

[0135] It is noted that the devices prepared according to the present invention are generally deep blue light devices, with CIEy values ​​generally less than 0.20. Sensitization of the device structure after addition of boron-containing compounds can further improve the purity of the emission color of the device by further reducing the CIEy value.

[0136] The applicant declares that the above is only any preferred embodiment of the present invention, and does not limit the protection scope of the present invention. Any changes or replacements that can be easily conceived within the technical scope disclosed in the present invention by anyone familiar with the art will be obvious to those skilled in the art and fall within the protection scope and disclosure scope of the present invention.

[0137] (Additional Note) (Appendix 1) A fluorine-containing tetradentate cyclometallated platinum(II) complex, the complex having a structure represented by formula (I) or formula (II): A fluorine-containing tetradentate cyclometallated platinum(II) complex. [ka] [In formula (I) or formula (II), F n represents one or more F substitutions on the benzene ring where n is a positive integer of 1 to 5; R a represents mono-, di-, tri-, tetra- or no substitution, and R a is selected from H or C1-C30 alkyl; R1, R2, and R3 are each independently selected from the group consisting of hydrogen, F, N, O, S, CN, a C1-C30 alkyl group, a C1-C30 cycloalkyl group, a C1-C30 cycloheteroalkyl group, a C1-C30 haloalkyl group, a C6-C60 aryl group, and a C6-C60 heteroaryl group.

[0138] (Appendix 2) At least one hydrogen atom of R1, R2, and R3 may be replaced with deuterium or F. 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1,

[0139] (Appendix 3) R1 and R3 are each independently selected from hydrogen or a C1-C30 alkyl group; 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1,

[0140] (Appendix 4) R2 is independently selected from hydrogen, deuterium, CN, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C1-C30 heteroalkyl group, a substituted or unsubstituted C1-C30 cycloalkyl group, a substituted or unsubstituted C1-C30 cycloheteroalkyl group, a substituted or unsubstituted C1-C30 haloalkyl group, a substituted or unsubstituted C6-C60 aryl group, and a substituted or unsubstituted C6-C60 heteroaryl group, and the heteroatoms on the heteroalkyl group, cycloheteroalkyl group, or heteroaryl group are selected from one or more of O, S, and / or N; 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1,

[0141] (Appendix 5) Selected from any one of the chemical structures shown below, where "D" represents deuterium: 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1, [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0142] (Appendix 6) Application of the fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of claims 1 to 5 in an electronic device.

[0143] (Appendix 7) The electronic devices include organic electroluminescent devices, organic integrated circuits, organic field effect transistors, organic thin film transistors, organic light emitting transistors, organic solar cells, organic photodetectors, organic photoreceptors, organic field quenchers, light emitting electrochemical cells and organic laser diodes; 7. The application according to claim 6,

[0144] (Appendix 8) An organic electroluminescence device comprising a cathode, an anode, and an organic functional layer interposed between the anode and the cathode, the organic functional layer containing a fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of appendices 1 to 5. An organic electroluminescence device comprising:

[0145] (Appendix 9) An organic electroluminescence device, wherein the organic functional layer includes a light-emitting layer, and the light-emitting layer contains a fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of claims 1 to 5. An organic electroluminescence device comprising:

[0146] (Appendix 10) The light-emitting layer also contains a fluorescent doping material selected from any one or more of the compounds represented by formulas (BN1) to (BN5). 10. The organic electroluminescence device according to claim 9, [ka] [In the formula, X is O, S, Se or NR 300 and X 1 , X 2 , X 3 , X 4 are each independently represented by O, S, Se or N, R b ~R e R each independently represents mono-, di-, tri-, tetra- or no substitution. b ~R e are each independently selected from the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group; R 11 each independently represents the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group.

[0147] (Appendix 11) R4 to R6 and R9 are each independently selected from a substituted or unsubstituted diphenylamine and a substituted or unsubstituted carbazolyl group, and the substitution may be multiple times. When the substituent is included, the substituent is selected from a deuterium atom, a C1-C30 alkyl group, and a C6-C30 aryl group. 11. The organic electroluminescence device according to claim 10,

[0148] (Appendix 12) Above R7~R8, R 10 ~R 11 are each independently selected from the group consisting of hydrogen, a C1-C30 alkyl group, and a C6-C60 aryl group; 11. The organic electroluminescence device according to claim 10,

[0149] (Appendix 13) The fluorescent doping material is selected from any one of the following chemical structural formulas, in which Ph represents a phenyl group, and D4 and D5 represent substituted with 4 and 5 deuterium atoms, respectively: 11. The organic electroluminescence device according to claim 10, [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0150] (Appendix 14) An organic optoelectronic device comprising a substrate layer, a first electrode on the substrate, an organic light-emitting functional layer on the first electrode, and a second electrode on the organic light-emitting functional layer, the organic light-emitting functional layer containing a fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of claims 1 to 5. An organic optoelectronic device comprising:

[0151] (Appendix 15) The organic light-emitting functional layer also contains a fluorescent doping material selected from any one or more of the compounds represented by formulas (BN1) to (BN5). 15. The organic optoelectronic device of claim 14. [ka] [In the formula, X is O, S, Se or NR 300 and X 1 , X 2 , X 3 , X 4 are each independently represented by O, S, Se or N, R b ~R e R each independently represents mono-, di-, tri-, tetra- or no substitution. b ~R e are each independently selected from the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group, 11 each independently represents the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group.

[0152] (Appendix 16) A composition comprising a fluorine-containing tetraplatinum (II) complex according to any one of claims 1 to 5. A composition comprising:

[0153] (Appendix 17) A preparation comprising a fluorine-containing tetraplatinum (II) complex according to any one of claims 1 to 5. A formulation characterized in that

[0154] (Appendix 18) A display or lighting device, comprising one or more organic electroluminescent devices according to any one of appendixes 10 to 13; A display or lighting device characterized in that:

Claims

1. A fluorine-containing tetradentate cyclometallated platinum(II) complex, the complex having a structure represented by formula (I) or formula (II): A fluorine-containing tetradentate cyclometallated platinum(II) complex, characterized in that 【Chemistry 1】 [In formula (I) or formula (II), F n represents one or more F substitutions on the benzene ring where n is a positive integer from 1 to 5; R a represents mono-, di-, tri-, tetra- or no substitution, and R a is selected from H or C1-C30 alkyl; R 1 , R 2 , R 3 are each independently selected from the group consisting of hydrogen, F, N, O, S, CN, a C1-C30 alkyl group, a C1-C30 cycloalkyl group, a C1-C30 cycloheteroalkyl group, a C1-C30 haloalkyl group, a C6-C60 aryl group, and a C6-C60 heteroaryl group.

2. R 1 , R 2 , R 3 At least one hydrogen atom may be replaced with deuterium or F.

2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1 .

3. The R 1 , R 3 are each independently selected from hydrogen or a C1-C30 alkyl group; 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1 .

4. The R 2 are each independently selected from hydrogen, deuterium, CN, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C1-C30 heteroalkyl group, a substituted or unsubstituted C1-C30 cycloalkyl group, a substituted or unsubstituted C1-C30 cycloheteroalkyl group, a substituted or unsubstituted C1-C30 haloalkyl group, a substituted or unsubstituted C6-C60 aryl group, and a substituted or unsubstituted C6-C60 heteroaryl group, and the heteroatoms on said heteroalkyl, cycloheteroalkyl or heteroaryl group are selected from one or more of O, S and / or N; 2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1 .

5. Selected from any one of the chemical structures shown below, where "D" represents deuterium:

2. The fluorine-containing tetradentate cyclometallated platinum(II) complex according to claim 1 . 【Chemistry 2-1】 【Chemistry 2-2】 【Chemistry 2-3】 【Chemistry 2-4】 【Chemistry 2-5】 【Chemistry 2-6】 【Chemistry 2-7】 【Chemistry 2-8】 【Chemistry 2-9】 【Chemistry 2-10】 【Chemistry 2-11】 【Chemistry 2-12】 【Chemistry 2-13】

6. Application of the fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of claims 1 to 5 in electronic devices.

7. The electronic devices include organic electroluminescent devices, organic integrated circuits, organic field effect transistors, organic thin film transistors, organic light emitting transistors, organic solar cells, organic photodetectors, organic photoreceptors, organic field quenchers, light emitting electrochemical cells and organic laser diodes; 7. The application according to claim 6 .

8. An organic electroluminescence device comprising a cathode, an anode, and an organic functional layer interposed between the anode and the cathode, the organic functional layer containing the fluorine-containing tetradentate cyclometallated platinum (II) complex according to any one of claims 1 to 5. An organic electroluminescence device comprising:

9. An organic electroluminescence device, wherein the organic functional layer includes a light-emitting layer, and the light-emitting layer contains the fluorine-containing tetradentate cyclometallated platinum(II) complex according to any one of claims 1 to 5. An organic electroluminescence device comprising:

10. The light-emitting layer also contains a fluorescent doping material selected from any one or more of the compounds represented by formulas (BN1) to (BN5).

10. The organic electroluminescent device according to claim 9 . 【Chemistry 3】 [Wherein, X is O, S, Se or NR 300 and X 1 , X 2 , X 3 , X 4 are each independently represented by O, S, Se or N; R b ~R e R each independently represents mono-, di-, tri-, tetra- or no substitution. b ~R e are each independently selected from the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group; R 4 ~R 11 each independently represents the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group.

11. The R 4 ~R 6 , R 9 are each independently selected from a substituted or unsubstituted diphenylamine, a substituted or unsubstituted carbazolyl group, the substitution may be multiple times, and when the substituents are included, the substituents are selected from deuterium, a C1-C30 alkyl group, and a C6-C30 aryl group; 11. The organic electroluminescent device according to claim 10.

12. The R 7 ~R 8 , R 10 ~R 11 are each independently selected from the group consisting of hydrogen, a C1-C30 alkyl group, and a C6-C60 aryl group; 11. The organic electroluminescent device according to claim 10.

13. The fluorescent doping material is selected from any one of the following chemical structural formulas, in which Ph represents a phenyl group, and D4 and D5 represent substitutions with 4 and 5 deuterium atoms, respectively:

11. The organic electroluminescent device according to claim 10. 【Chemistry 4-1】 【Chemistry 4-2】 【Chemistry 4-3】 【Chemistry 4-4】 【Chemistry 4-5】 【Chemistry 4-6】 【Chemistry 4-7】 【Chemistry 4-8】

14. An organic optoelectronic device comprising a substrate layer, a first electrode on the substrate, an organic light-emitting functional layer on the first electrode, and a second electrode on the organic light-emitting functional layer, the organic light-emitting functional layer containing the fluorine-containing tetradentate cyclometallated platinum (II) complex according to any one of claims 1 to 5. An organic optoelectronic device comprising:

15. The organic light-emitting functional layer also contains a fluorescent doping material selected from any one or more of the compounds represented by formulas (BN1) to (BN5).

15. The organic optoelectronic device of claim 14. 【Chemistry 5】 [Wherein, X is O, S, Se or NR 300 and X 1 , X 2 , X 3 , X 4 are each independently represented by O, S, Se or N; R b ~R e R each independently represents mono-, di-, tri-, tetra- or no substitution. b ~R e are each independently selected from the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group; 4 ~R 11 each independently represents the group consisting of hydrogen, deuterium, N, a C1-C30 alkyl group, and a C6-C60 aryl group.

16. A composition comprising the fluorine-containing tetraplatinum (II) complex according to any one of claims 1 to 5. A composition comprising:

17. A preparation comprising the fluorine-containing tetraplatinum (II) complex according to any one of claims 1 to 5. A formulation characterized in that

18. A display or lighting device comprising one or more organic electroluminescent devices according to claim 10. A display or lighting device characterized in that:

Citation Information

Patent Citations

  • Organic electroluminescent materials and devices

    EP4039692A1

  • Organic electroluminescent materials and devices

    US20200140471A1